We are live on ! Find out more
BCAB icon

BioAtla
BCAB

97 hedge funds and large institutions have $128M invested in BioAtla in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 12

68% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 19

37% more call options, than puts

Call options by funds: $596K | Put options by funds: $436K

23% more funds holding

Funds holding: 79 → 97 (+18)

0.07% less ownership

Funds ownership: 1.49% → 1.43% (-0.07%)

75% less capital invested

Capital invested by funds: $518M → $128M (-$391M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
97
Holders Change
+18
Holders Change %
+22.78%
% of All Funds
1.53%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
32
Reduced
19
Closed
12
Calls
$596K
Puts
$436K
Net Calls
+$160K
Net Calls Change
-$1.77M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$7.81M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$6.9M
3
TCM
Tang Capital Management
California
+$6.71M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.89M
5
Two Sigma Investments
Two Sigma Investments
New York
+$3.23M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$19.4M
2
GPP
Great Point Partners
Connecticut
-$17M
3
PA
Perceptive Advisors
New York
-$13M
4
WP
Woodline Partners
California
-$8.76M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$871K -$50.2K -120 -3%
Walleye Capital
27
Walleye Capital
New York
$852K +$1.43M +3,407 New
TI
28
Trexquant Investment
Connecticut
$577K +$806K +1,926 +506%
OQS
29
Occudo Quantitative Strategies
Florida
$577K +$966K +2,309 New
N
30
Nuveen
North Carolina
$572K +$440K +1,051 +101%
Bank of America
31
Bank of America
North Carolina
$549K +$553K +1,322 +151%
Charles Schwab
32
Charles Schwab
California
$531K -$105K -250 -11%
Squarepoint
33
Squarepoint
New York
$525K +$738K +1,765 +524%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$521K +$627K +1,498 +255%
Citadel Advisors
35
Citadel Advisors
Florida
$505K +$490K +1,172 +138%
PP
36
PDT Partners
New York
$477K +$798K +1,908 New
PIM
37
Platinum Investment Management
Australia
$456K – – –
Marshall Wace
38
Marshall Wace
United Kingdom
$445K +$485K +1,160 +186%
SSA
39
Schonfeld Strategic Advisors
New York
$367K +$613K +1,466 New
CSS
40
Cubist Systematic Strategies
Connecticut
$356K +$150K +359 +34%
Los Angeles Capital Management
41
Los Angeles Capital Management
California
$333K +$557K +1,332 New
Barclays
42
Barclays
United Kingdom
$333K +$558K +1,334 New
MA
43
MYDA Advisors
New York
$300K +$502K +1,200 New
Russell Investments Group
44
Russell Investments Group
United Kingdom
$286K +$479K +1,144 New
Bank of New York Mellon
45
Bank of New York Mellon
New York
$254K – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$251K +$63.6K +152 +18%
Jane Street
47
Jane Street
New York
$205K +$343K +821 New
JF
48
Jump Financial
Illinois
$203K +$110K +262 +48%
VF
49
Virtu Financial
New York
$196K +$328K +785 New
AA
50
ALPS Advisors
Colorado
$191K -$37.2K -89 -10%
1
2
3 4 5

BCAB Hedge Fund Activity: Q1 2022 in Review

97 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q1 2022, worth a combined $128M — down 75% from $518M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new BCAB positions and 12 closed out — a net gain of 18 holders — while 32 added to existing stakes and 19 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $7.81M. The largest seller was Wellington Management Group, cutting an estimated $19.4M.

  • 97 institutional investors held BioAtla (BCAB) as of Q1 2022, up from 79 in Q4 2021.
  • Funds reported $128M of BioAtla stock for Q1 2022, down 75% quarter-over-quarter.
  • 30 funds opened new BioAtla positions in Q1 2022 and 12 closed out, a net change of +18 holders.
  • The largest BioAtla buyer in Q1 2022 was Morgan Stanley, an estimated $7.81M added.
  • The largest BioAtla seller in Q1 2022 was Wellington Management Group, an estimated $19.4M sold.

Based on aggregated 13F filings for Q1 2022.